INTERNATIONAL PATENT: FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) FILES APPLICATION FOR "GENETIC REPROGRAMMING BY RE-EXPRESSION OF ESE3/EHF FOR THE TREATMENT OF ADVANCED PROSTATE CANCER"

GENEVA, Feb. 17 -- FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) (Via Francesco Chiesa 56500 Bellinzona) filed a patent application (PCT/IB2025/057866) for "GENETIC REPROGRAMMING BY RE-EXPRESSION OF ESE3/EHF FOR THE TREATMENT OF ADVANCED PROSTATE CANCER" on Aug 01, 2025. With publication no. WO/2026/033361, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CARBONE, Giuseppina (c/o Fondazione per l'Istituto Oncologico di Ricerca (IOR)Via Francesco Chiesa, 56500 Bellinzona), CATAPANO, Carlo (c/o Fondazione per l'Istit...